Literature DB >> 23148166

Endocrine and metabolic emergencies: hypercalcaemia.

Richard Carroll1, Glenn Matfin.   

Abstract

Hypercalcaemia is commonly seen in the context of parathyroid dysfunction and malignancy and, when severe, can precipitate Life-threatening sequelae. The differential of hypercalcaemia is broad and can be categorized based on parathyroid hormone (PTH) Levels. The acute management of severe hypercalcaemia is discussed along with a brief review of therapeutic advances in the field.

Entities:  

Keywords:  hypercalcaemia; hypercalcaemic crisis; hyperparathyroidism; malignancy-associated hypercalcaemia

Year:  2010        PMID： 23148166      PMCID： PMC3474617          DOI： 10.1177/2042018810390260

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN： 2042-0188            Impact factor:   3.565


  25 in total

Review 1.  Clinical practice. Hypercalcemia associated with cancer.

Authors:  Andrew F Stewart
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

2.  Osteonecrosis of the jaw--do bisphosphonates pose a risk?

Authors:  John P Bilezikian
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 4.  Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide.

Authors:  A E Broadus; M Mangin; K Ikeda; K L Insogna; E C Weir; W J Burtis; A F Stewart
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

Authors:  P Major; A Lortholary; J Hon; E Abdi; G Mills; H D Menssen; F Yunus; R Bell; J Body; E Quebe-Fehling; J Seaman
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

Review 6.  Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.

Authors:  Sakae Tanaka; Kozo Nakamura; Naoyuki Takahasi; Tatsuo Suda
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

7.  Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.

Authors:  Frédérique Cvitkovic; Jean-Pierre Armand; Michèle Tubiana-Hulin; Jean-François Rossi; Raymond P Warrell
Journal:  Cancer J       Date:  2006 Jan-Feb       Impact factor: 3.360

8.  Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.

Authors:  S H Ralston; D Thiébaud; Z Herrmann; E U Steinhauer; B Thürlimann; J Walls; M R Lichinitser; R Rizzoll; H Hagberg; H J Huss; M Tubiana-Hulin; J J Body
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease.

Authors:  Martin Hewison; Fiona Burke; Katie N Evans; David A Lammas; David M Sansom; Philip Liu; Robert L Modlin; John S Adams
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03       Impact factor: 4.292

10.  A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.

Authors:  O P Purohit; C R Radstone; C Anthony; J A Kanis; R E Coleman
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
View more
  11 in total

Review 1.  Neurological Complications of Endocrine Emergencies.

Authors:  Salvador Cruz-Flores
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-11       Impact factor: 5.081

Review 2.  Endocrine Emergencies With Neurologic Manifestations.

Authors:  Makoto Ishii
Journal:  Continuum (Minneap Minn)       Date:  2017-06

3.  The Global Spine Care Initiative: a review of reviews and recommendations for the non-invasive management of acute osteoporotic vertebral compression fracture pain in low- and middle-income communities.

Authors:  Arthur Ameis; Kristi Randhawa; Hainan Yu; Pierre Côté; Scott Haldeman; Roger Chou; Eric L Hurwitz; Margareta Nordin; Jessica J Wong; Heather M Shearer; Anne Taylor-Vaisey
Journal:  Eur Spine J       Date:  2017-10-16       Impact factor: 3.134

4.  Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report.

Authors:  Jairo Arturo Noreña; César Daniel Niño; Sabrina Gallego; Carlos Alfonso Builes-Barrera; Diva Cristina Castro; Alejandro Román-González; Camilo Jimenez
Journal:  Clin Cases Miner Bone Metab       Date:  2017-12-27

5.  Targeted 25-hydroxyvitamin D3 1α-hydroxylase adoptive gene therapy ameliorates dss-induced colitis without causing hypercalcemia in mice.

Authors:  Bo Li; David J Baylink; Michael H Walter; Kin-Hing William Lau; Xianmei Meng; Jun Wang; Andriy Cherkas; Xiaolei Tang; Xuezhong Qin
Journal:  Mol Ther       Date:  2014-10-20       Impact factor: 11.454

6.  Adrenal crisis presented as acute onset of hypercalcemia and hyponatremia triggered by acute pyelonephritis in a patient with partial hypopituitarism and pre-dialysis chronic kidney disease.

Authors:  Shunsuke Yamada; Hokuto Arase; Toshifumi Morishita; Akihiro Tsuchimoto; Kumiko Torisu; Takehiro Torisu; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2018-11-19

Review 7.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

8.  Life-Threatening Hypercalcemia due to Graves' Disease and Concomitant Adrenal Failure: A Case Report and Review of the Literature.

Authors:  Hande Mefkure Ozkaya; Fatma Ela Keskin; Ozlem Asmaz Haliloglu; Tugba Elif Senel; Pinar Kadioglu
Journal:  Case Rep Endocrinol       Date:  2015-03-24

9.  Diagnostic accuracy of the defining characteristics of the excessive fluid volume diagnosis in hemodialysis patients.

Authors:  Maria Isabel da Conceição Dias Fernandes; Miclécia de Melo Bispo; Érida Maria Diniz Leite; Marcos Venícios de Oliveira Lopes; Viviane Martins da Silva; Ana Luisa Brandão de Carvalho Lira
Journal:  Rev Lat Am Enfermagem       Date:  2015 Nov-Dec

10.  High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial.

Authors:  Atthakorn Jarusriwanna; Suchat Phusunti; Pojchong Chotiyarnwong; Aasis Unnanuntana
Journal:  BMC Geriatr       Date:  2021-01-21       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.